Showing results (181-190 of 242) with videos related to
Sort By:
Pageof 25
Scientific Reports|August 23, 2018
Mutant allele quantification reveals a genetic basis for TP53 mutation-driven castration resistance in prostate cancer cellsKefeng Lei, Ran Sun, Lee H Chen, et al.Cancer Immunology Research|January 30, 2016
CAR T Cells Targeting Podoplanin Reduce Orthotopic Glioblastomas in Mouse BrainsSatoshi Shiina, Masasuke Ohno, Fumiharu Ohka, et al.Cancer Immunology Research|November 21, 2025
Lymphotropic Virotherapy Induces DC and High Endothelial Venule Inflammation, Promoting the Antitumor Efficacy of Intratumor Virus AdministrationAndrea L Ludwig, Zachary P McKay, Griffin P Carter, et al.The New England Journal of Medicine|February 21, 2009
IDH1 and IDH2 mutations in gliomasHai Yan, D Williams Parsons, Genglin Jin, et al.Neuro-Oncology|April 17, 2007
Clinical utility of a patient-specific algorithm for simulating intracerebral drug infusionsJohn H Sampson, Raghu Raghavan, Martin L Brady, et al.Cancers|September 28, 2023
Repurposing Clemastine to Target Glioblastoma Cell StemnessMichael A Sun, Rui Yang, Heng Liu, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 29, 2008
Development of a real-time RT-PCR assay for detecting EGFRvIII in glioblastoma samplesKoji Yoshimoto, Julie Dang, Shaojun Zhu, et al.Investigational New Drugs|January 6, 2016
Preclinical toxicity evaluation of a novel immunotoxin, D2C7-(scdsFv)-PE38KDEL, administered via intracerebral convection-enhanced delivery in ratsXuhui Bao, Vidyalakshmi Chandramohan, Randall P Reynolds, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 22, 2005
ZD6474, a novel tyrosine kinase inhibitor of vascular endothelial growth factor receptor and epidermal growth factor receptor, inhibits tumor growth of multiple nervous system tumorsJeremy N Rich, Sith Sathornsumetee, Stephen T Keir, et al.Journal for Immunotherapy of Cancer|September 29, 2022
Multimodality analysis confers a prognostic benefit of a T-cell infiltrated tumor microenvironment and peripheral immune status in patients with melanomaGeorgia M Beasley, Michael C Brown, Norma E Farrow, et al.Pageof 25